Review article: The role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue SUPPL. 2, 2006, Pages 10-16

  Tack, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIOXIDANT; BACLOFEN; BILE ACID; CARBONATE DEHYDRATASE; CISAPRIDE; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; PEPSIN A; PROKINETIC AGENT; PROTON PUMP INHIBITOR; UVOMORULIN;

BILE; CLINICAL TRIAL; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STOMACH ACID; SYMPTOM;

EID: 33747615235     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03040.x     Document Type: Review

References (77)

1. Kahrilas PJ, Quigley FM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-96.
2. Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut 2005; 54: 1492-9.
3. Tack J. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease. Curr Opin Gastroenterol 2005; 21: 454-60.
4. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal injury: a review of animal and human studies. Gastroenterology 1995; 108: 1897-907.
5. Tack J. Review article: role of pepsin and bile in gastro-esophageal reflux disease. Aliment Pharmacol Ther 2005; 22 (Suppl. 1): 48-54.
6. Mearin F, Azpiroz F, Malagelada JR, Zinsmeister AR. Antroduodenal resistance to flow in the control of duodenogastric bile reflux during fasting. Gastroenterology 1987; 93: 1026-33.
7. Koek G, Vos R, Sifrim D, Cuomo R, Janssens J, Tack J. Mechanisms underlying duodeno-gastric reflux in man. Neurogastroenterol Motil 2005; 17: 191-9.
8. Bremner RM, Crookes PF, DeMeester TR, Peters JH, Stein HJ. Concentration of refluxed acid and esophageal mucosal injury. Am J Surg 1992; 164: 522-6.
9. Dent J. Roles of gastric acid and pH in the pathogenesis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1994; 201 (Suppl): 55-61.
10. Gotley DC, Morgan AP, Ball D, Owens RW, Cooper MJ. Bile acid concentrations in the refluxate of patients with reflux oesophagitis. Br J Surg 1988; 75: 587-90.
11. Johnsson F, Joelsson B, Floren CH, et al. Bile salts in the esophagus of patients with esophagitis. Scand J Gastroenterol 1988; 23: 712-6.
12. Gotley DC, Morgan AP, Ball D, Owen RW, Cooper MJ. Composition of gastrooesophageal refluxate. Gut 1991; 32: 1093-9.
13. Stipa F, Stein HJ, Feussner H, Kraemer S, Siewert JR. Assessment of non-acidic esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus 1997; 10: 24-28.
14. Tasker A, Dettmar PW, Panetti M, Koufman JA, Birchall JP, Pearson JP. Reflux of gastric juice and glue ear in children. Lancet 2002; 359: 493.
15. Tasker A, Dettmar PW, Panetti M, Koufman JA, Birchall JP, Pearson JP. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope 2002; 112: 1930-4.
16. Metheny NA, Chang YH, Ye JS, et al. Pepsin as a marker for pulmonary aspiration. Am J Crit Care 2002; 11: 150-4.
17. Nasrallah SM, Johnston GS, Gadacz TR, et al. The significance of gastric bile reflux at endoscopy. J Clin Gastroenterol 1987; 9: 514-7.
18. Stein HJ, Smyrck TC, DeMeester TR, et al. Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease. Surgery 1992; 112: 796-804.
19. Drane WE, Karvelis K, Johnson DA, et al. Scintigrafic evaluation of duodenogastric reflux. Problems, pitfalls and technical review. Clin Nucl Med 1987; 12: 377-84.
20. Singh S, Bradley LA, Richter JE. Determinants of esophageal alkaline pH environment in controls and patients with gastroesophageal reflux disease. Gut 1993; 34: 309-16.
21. Devault KR, Georgson S, Castell DO. Salivary stimulation mimics esophageal exposure to refluxed duodenal contents. Am J Gastroenterol 1993; 88: 1040-3.
22. Fass J, Silny J, Braun J, et al. Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients. Scand J Gastroenterol 1994; 29: 693-720.
23. Sifrim D, Holloway R, Silny J, Tack J, Lerut A, Janssens J. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 647-55.
24. Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hr pH-Impedance recordings. Gastroenterology 2001; 120: 1588-98.
25. Sifrim D, Castell D, Kent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid and gas reflux. Gut 2004; 53: 1024-31.
26. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995; 108: 1897-907.
27. Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969; 56: 223-30.
28. Harmon JW, Johnson LF, Maydonovitch CL. Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 1981; 26: 65-72.
29. Lillemoe KD, Johnson LF, Harmon JW. Role of the components of the gastroduodenal contents in experimental acid esophagitis. Surgery 1982; 92: 276-84.
30. Salo JA, Kivilaakso E. Contribution of trypsin and cholate to the pathogenesis of experimental alkaline reflux esophagitis. Scand J Gastroenterol 1984; 19: 875-81.
31. Johnson LF, Harmon JW. Experimental esophagitis in a rabbit model. Clinical relevance. J Clin Gastroenterol 1986; 8 (Suppl 1): 26-44.
32. Pursnani KG, Mohiuddin MA, Geisinger KR, Weinbaum G, Katzka DA, Castell DO. Experimental study of acid burden and acute oesophagitis. Br J Surg 1998; 85: 677-80.
33. Lanas A, Royo Y, Ortego J, Molina M, Sainz R. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology. 1999; 116: 97-107.
34. Lanas AI, Blas JM, Ortego J, Soria J, Sainz R. Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor. Dig Dis Sci 1997; 42: 1003-12.
35. Tobey NA, Hosseini SS, Caymaz-Bor C, Wyatt HR, Orlando GS, Orlando RC. The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol 2001; 96: 3062-70.
36. Naya MJ, Pereboom D, Ortego J, Alda JO, Lanas A. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oseophagitis in rabbits. Gut 1997; 40: 175-81.
37. Adhami T, Goldblum JL, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004; 99: 2098-106.
38. Johnston N, Dettmar PW, Lively MO, et al. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol 2006; 115: 47-58.
39. Gelbmann CM, Schteingart CD, Thompson SM, Hofmann AF, Barrett KE. Mast cells and histamine contribute to bile acid-stimulated secretion in the mouse colon. J Clin Invest 1995; 95: 2831-9.
40. Miwa K, Sahara H, Segawa M, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996; 67: 269-74.
41. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001; 121: 1391-9.
42. Hopwood D, Bateson MC, Milne G, Bouchier IA. Effects of bile acids and hydrogen ion on the fine structure of oesophageal epithelium. Gut 1981; 22: 306-11.
43. Gotley DC, Flaks B, Cooper MJ. Bile acids do not modify the effects of pepsin on the fine structure of human oesophagal epithelium. Aust N Z J Surg 1992; 62: 579-75.
44. Tselepis C, Morris CD, Wakelin D, et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 2003; 52: 174-80.
45. Sears RJ, Champion GL, Richter JE. Characteristics of distal partial gastrectomy patients with oesophageal symptoms of duodeno-gastric reflux. Am J Gastroenterol 1995; 90: 211-5.
46. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodeno-gastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994; 107: 747-54.
47. Caldwell MT, Lawlor P, Byrne PJ, Walsh TN, Hennessy TP. Ambulatory oesophageal bile reflux monitoring in Barrett's esophagus. Br J Surg 1995; 82: 657-60.
48. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117: 699-704.
49. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525-31.
50. Cuomo R, Koek G, Sifrim D, Janssens J, Tack J. Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 2000; 45: 2463-9.
51. Tack J, Bisschops R, Koek G, Sifrim D, Lerut T, Janssens J. Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux. Dig Dis Sci 2003; 48: 1213-30.
52. Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 2001; 136: 1267-73.
53. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Esophagitis and Barrett's esophagus: acid reflux, bile reflux or both? Gastroenterology 2000; 188(Suppl.): a224 (abstract).
54. Orlando RC, Bozymski EM. Heartburn in pernicious anemia - a consequence of bile reflux. N Engl J Med 1973; 289: 522-3.
55. Wilmer A, Tack J, Frans E, et al. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999; 116: 1239-9.
56. Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol 2003; 112: 481-91.
57. Smith JL, Opekun AR, Larkai E, Graham DY. Sensitivity of the eospahgeal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989; 96: 683-9.
58. Siddiqui A, Rodriguez-Stanley S, Zubaidi S, Miner PB. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig Dis Sci 2005; 50: 81-5.
59. Marshall RE, Anggiansah A, Owen WA, Owen WJ. The relationship between acid and bile reflux and symptoms in gastroesophageal reflux disease. Gut 1997; 40: 182-7.
60. Koek GH, Tack J, Sifrim D, Lerut T, Janssans J. The role of acid and duodenal gastroesophageal reflux in symptomatic GERD. Am J Gastoenterol 2001; 96: 2033-40.
61. Vela M, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and non-acid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599-606.
62. Tack J, Koek G, Demedts I, Sifrim D, Janssens J. Gastro-esophageal reflux disease poorly responsive to single dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux or both?. Am J Gastroenterol 2004; 99: 981-9.
63. Marshall RE, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-osophageal bile reflux in barrett's esophagus. Gut 1998; 43: 603-6.
64. Stein HJ, Kauer WK, Feussner H, Siewert JR. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998; 2: 333-41.
65. Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001; 96: 331-7.
66. Vaezi MF, Sears R; Richter JE. Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux. Dig Dis Sci 1996; 41: 754-63.
67. Penagini R, Schoeman MN, Dent J, Tippett MD, Holloway R. Motor events underlying gastro-esophageal reflux in ambulant patients with reflux esophagitis. Neurogastroenterol Motil 1996; 8: 131-41.
68. Schoeman MN, Tippett MD, Akkermans LMA, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995; 108: 83-91.
69. Lidums I, Lehmann A, Cheklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
70. Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 05: 19-24.
71. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. The effect of the GABAb agonist baclofen in patients with symptoms and duodenogastro-esophageal reflux refractory to proton pump inhibitors. Gut 2003; 10: 1397-402.
72. Oh TY, Lee JS, Ahn BO, et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 2001; 49: 364-71.
73. Batchelor H, Craig D, Dettmar PW, Jolliffe I, Hampson F. Investigation into the rheological synergy between salivary mucins and alginate. 19th Pharmaceutical Technology Conference Vol. 1. 2000: Great Britain, pp. 39-43.
74. Richardson JC, Dettmar PW, Hampson FC, Melia CD. Oesophageal bioadhesion of sodium alginate suspensions: particle swelling and mucosal retention. Eur J Pharm Sci 2004; 23: 49-56.
75. Tang M, Dettmar P, Batchelor H. Bioadhesive oesophageal bandages: protection against acid and pepsin injury. Int J Pharm 2005; 292: 169-77.
76. Strugala V, Kennington EJ, Campbell RJ, Skjak-Braek G, Dettmar PW. Inhibition of pepsin activity by alginates in vitro and the effect of epimerization. Int J Pharm 2005; 304: 40-50.
77. Flo TH, Ryan L, Kilaas L, et al. Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers. Infect Immun 2000; 68: 6770-6.